Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-03
2006-10-03
Tsang, Cecilia J. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S135000, C546S115000, C549S072000, C549S006000, C544S349000
Reexamination Certificate
active
07115654
ABSTRACT:
The invention provides compounds of Formula I and derivatives thereof, pharmaceutical compositions comprising a compound of Formula I, and methods of treatment utilizing such compounds and compositions:wherein:R1is chosen from optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, and optionally substituted heteroaralkyl;L is a linker;R2is chosen from optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, and optionally substituted heteroaralkyl; andor single stereoisomers, mixtures of stereoisomers, or the pharmaceutically acceptable salts, amides, or esters thereof.
REFERENCES:
patent: 6153591 (2000-11-01), Cai et al.
patent: 6204261 (2001-03-01), Batchelor et al.
patent: 6566338 (2003-05-01), Weber et al.
patent: 6878743 (2005-04-01), Choong et al.
patent: 2004/0048797 (2004-03-01), Miller et al.
patent: WO 99/56765 (1999-11-01), None
patent: WO 02/094263 (2002-11-01), None
patent: WO 03/024955 (2003-03-01), None
International Search Report for PCT/US03/18021, mailed on May 27, 2004, 4 pages.
Relton et al., (1992)Brain Research Bulletin, 29:243-246.
Elford et al., (1995)British Journal of Pharmacology115:601-606.
Miura et al., (1993)Cell, 75:653-660.
Alnerni et al., (1996)Cell, 87:171.
Thornberry et al., (1997)J. Biol. Chem.272:17907-17911.
Ghayur et al. (1997)Nature386:619-623.
Allen Darin
Fahr Bruce
Oslob Johan
Raimundo Brian C.
Romanowski Michael J.
Balls James
Choate Hall & Stewart LLP
Herschbach Jarrell Brenda
Lagneau Nadège M
Sunesis Pharmaceuticals, Inc.
LandOfFree
Caspase-1 inhibitors and methods for their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Caspase-1 inhibitors and methods for their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Caspase-1 inhibitors and methods for their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3675947